Figure 2 | Scientific Reports

Figure 2

From: Comparative Meta-Analysis of Tenofovir Disoproxil Fumarate versus Emtricitabine and Tenofovir Disoproxil Fumarate as Treatments for Patients with Chronic Hepatitis B

Figure 2

Forest plot displaying the primary outcomes of viral suppression efficacy for CHB patients at different time points after treatments with TDF alone and FTC/TDF combination, respectively.

Forest plot showed viral suppression efficacy for CHB patients with nucleos(t)ide-(or naïve) treatment history after (a) 12 weeks, (b) 24 weeks, (c) 48 weeks, (d) 96 weeks and (e) 192 weeks of treatments with TDF alone and FTC/TDF combination, respectively.

Back to article page